News

Kane Biotech Partners with Razan Medical for Wound Care Solution

Kane Biotech Partners with Razan Medical for Wound Care Solution

Kane Biotech Forms Distribution Agreement with Razan Medical Trading

Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) is thrilled to announce a major partnership with Razan Medical Trading for the distribution of its cutting-edge revyve™ Antimicrobial Wound Gel in the Middle East. This agreement is a significant step towards improving wound care solutions in the UAE, with the goal of providing high-quality products for both medical professionals and patients.

Highlights of the Partnership

The three-year collaboration, recently unveiled, underscores a mutual commitment to enhancing medical care. Hussain Malkawi, Managing Director of Razan Medical Trading, expressed their dedication to healthcare innovation. He noted that this partnership is a testament to their ongoing mission to transform wound care from prevention to effective healing practices.

The Importance of revyve™ in the UAE Market

Revyve™ is a state-of-the-art antimicrobial wound gel aimed at improving healing and preventing infections. This product reflects Kane Biotech's dedication to creating effective solutions in the healthcare industry. The distribution agreement with Razan Medical signifies Kane's entry into the UAE wound care market, further solidifying the brand’s aspirations for global expansion.

Previous Distribution Agreements

This partnership is not the first for Kane Biotech; it marks the third distribution agreement for revyve™. The company previously established collaborations with ProgenaCare Global LLC for the United States market and Salud Pharma S.A. for Colombia, Costa Rica, and Panama. These agreements highlight Kane's success in forming strategic partnerships to enhance product distribution.

Company Overview: Kane Biotech

Kane Biotech is at the forefront of biotechnology, concentrating on the research, development, and commercialization of technologies and products that combat microbial biofilms. Their impressive portfolio includes innovative products supported by a robust intellectual property framework, featuring 68 patents (both granted and pending), trade secrets, and trademarks. Among their notable trademarks are DispersinB®, Aledex™, coactiv+™, DermaKB™, and the newly launched revyve™.

Kane’s Ongoing Achievements

Recently, Kane Biotech achieved ISO 13485:2016 Medical Device Single Audit Program (MDSAP) certification, indicating their readiness to further commercialize revyve™ in Canada. This accomplishment underscores the company's commitment to operational excellence and adherence to regulatory standards.

About Razan Medical Trading

Established in 2015, Razan Medical Trading specializes in the distribution of medical equipment and consumables throughout the MENA region. Led by Mr. Hussain Malkawi, the company boasts over 30 years of experience in managing multinational healthcare businesses. Their local expertise strategically positions them to enhance the visibility and impact of new medical products, including revyve™.

Impact on Regional Healthcare

This collaboration aims to introduce advanced healthcare solutions in the UAE. By merging Kane Biotech’s innovative products with Razan Medical's regional market insights, the partnership is set to significantly enhance patient care and recovery processes across the region.

Conclusion

Kane Biotech's distribution agreement with Razan Medical Trading represents an exciting milestone in the company’s growth within the international wound care market. As both parties work together towards shared objectives, they are optimistic about the future of wound care solutions in the UAE, which will benefit countless patients and healthcare providers.

Frequently Asked Questions

What is revyve™ Antimicrobial Wound Gel?

Revyve™ is an innovative antimicrobial wound gel developed by Kane Biotech to enhance healing and prevent infections in wounds.

Who is partnered with Kane Biotech for the distribution of revyve™?

Kane Biotech has partnered with Razan Medical Trading to distribute revyve™ in the UAE market.

What are the benefits of using revyve™?

Revyve™ promotes effective healing through its antimicrobial properties, which help reduce the risk of infections in wounds.

When did Kane Biotech announce the distribution agreement?

The distribution agreement with Razan Medical Trading was announced on a recent date.

What other markets has Kane Biotech entered?

Kane Biotech has formed agreements for revyve™ in the United States and various countries in Central America including Colombia, Costa Rica, and Panama.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

The Chemical Industry and EPA: A Broken System?

Updated Category News Views 0

Decades of an Unchecked Revolving Door The Environmental Protection Agency (EPA) and chemical manufacturers—a dance that’s been going on for what seems like forever. But not in the way you might hope. We're talking about a revolving door where execs and lobbyists waltz into regulatory chairs while regulators slide into cushy industry gigs. Wisner Baum LLP, a stickler...

Continue Reading
Anecdotes by Artists Brings Raw Scent Stories to Sephora

Updated Category News Views 0

When Maesa pulls back the curtain, they don't just crack it open—they fling it aside with flair. That's precisely what they're doing with their latest venture, Anecdotes by Artists, a fragrance brand that's taking its first bow exclusively at Sephora. It's not your average perfume launch; it's about the stories behind the scents and the artists who craft them. Unveiling...

Continue Reading
FutureVault's AI Agents: Transforming Financial Workflows

Updated Category News Views 0

Revolutionizing Financial Operations: FutureVault's AI Approach In the dizzying whirlwind of financial services, the launch of FutureVault AI Agents is a game-changer for document management. This isn't some half-baked tool; it's a full-fledged overhaul of how compliance and operations should tick in the modern age. We've all seen it—a paper trail tangled across systems...

Continue Reading
HTX's Strategic Moves in Pakistan: A Crypto Frontier

Updated Category News Views 0

Paving the Way: HTX's Journey in Pakistan Rolling into the Pakistan cryptocurrency scene isn't just a 'walk in the park' for HTX—it's more like traversing a new frontier with an open map. This isn’t some hit-and-run operation; HTX is strategizing for a long haul in one of the liveliest digital market arenas in South Asia. Gathering steam with community AMAs and an X...

Continue Reading
Davos Healthcare Aims to Revolutionize Hospital Ratings

Updated Category News Views 0

Throw away those dusty, old reputation surveys—Davos Healthcare just turned the spotlight onto cold, hard data with its new global hospital evaluation platform. Why Davos Healthcare’s Initiative Matters At the C3 US NYC Davos of Healthcare™ Summit, an event that’s rooted itself alongside the United Nations General Assembly, Davos Healthcare unveiled a...

Continue Reading
Sean Trahan Joins Citrin Cooperman: New Tax Lead

Updated Category News Views 0

Citrin Cooperman's Strategic Tax Move If there's one phrase that can spark a debate at a financial water cooler, it's 'transfer pricing.' Today, Citrin Cooperman is throwing its hat further into that ring with the appointment of Sean Trahan as head of their new Transfer Pricing and Value Chain Optimization Practice. This isn't just another reshuffling of office...

Continue Reading
Succession Planning in Turmoil: Only 42% Ready

Updated Category News Views 3

Diving into the Succession Crisis in Finance Succession planning in the financial advisory space is like retirement planning for the rest of us—everyone knows it's crucial, yet too many put it off. Despite the looming retirement wave and desperate interest from the younger cohort, a staggering 42% of financial advisors are still without a documented succession game...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 3

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 6

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
FJBio Boosts Antibody Discovery with Sapio AI

Updated Category News Views 0

In the sprawling world of antibody discovery, where every scrap of data can make or break the next big breakthrough, FairJourney Bio (FJBio) is pulling out all the stops. They've teamed up with Sapio Sciences to ditch the paperwork nightmares and usher in a new era of AI-driven efficiency. With operations stretching from Porto to Cambridge to sunny San Diego, they’re...

Continue Reading

Top 5 Most Recently Viewed Articles

Verizon Communications Options Activity Highlights and Insights

Updated Category News Views 136

Verizon Communications Options Activity Insights Investors have been keeping a close eye on Verizon Communications as recent activity indicates an intriguing trend. Notably, large investors have been exhibiting a bearish attitude towards Verizon Communications. Analyzing the Options Activity Upon reviewing the options history for Verizon Communications (VZ), we identified...

Continue Reading
Economic Insights: Dollar, Treasury ETFs, and Oil Market Trends

Updated Category News Views 478

The Dynamics of Today’s Economic Landscape The world of economics is continuously evolving, and this week has proven to be particularly eventful. From debates about the U.S. dollar's role in global finance to fluctuations in oil prices, there are many essential updates to consider. Let’s explore these pivotal developments that have caught the attention of investors...

Continue Reading
Forecasted Growth of US Unmanned Surface Vehicles Market

Updated Category News Views 105

Overview of the US Unmanned Surface Vehicles Market The US unmanned surface vehicles (USVs) market is on a remarkable trajectory, expected to reach $362.4 million by 2028. Estimated at $247.2 million in 2024, this signifies a robust compound annual growth rate (CAGR) of 9.5% throughout the forecast period. Enhancements in technology and an increasing reliance on USVs for...

Continue Reading
Understanding Balanced Commercial Property Trust Limited Disclosures

Updated Category News Views 173

Public Opening Position Disclosure Overview In the world of finance and investing, transparency is key. For companies like Balanced Commercial Property Trust Limited, adhering to disclosure regulations is vital. This article delves into the details surrounding public opening position disclosures and the responsibilities of significant shareholders as outlined under Rule...

Continue Reading
BCA Research Upgrades Auto Sector Boosted by Tesla Revival

Updated Category News Views 221

BCA Research Upgrades Auto Sector Amid Tesla’s Recovery BCA Research has recently elevated its perspective on the Auto & Components sector to an overweight position. This change is attributed to a notable resurgence led by Tesla's (NASDAQ: TSLA) surprising performance in the third quarter. Tesla's Dominance in the Auto Market Tesla continues to hold a substantial...

Continue Reading